TONJA MOODY: Open Payments
NPI 1134389562 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,550 in 80 payments from 20 companies in 2025. Trend: 2023 $628 · 2024 $766 · 2025 $1,550
Food & beverage: $1,550
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 11 | $271 |
| Ipsen Biopharmaceuticals, Inc | 10 | $223 |
| Intercept Pharmaceuticals, Inc. | 19 | $203 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $163 |
| Gilead Sciences, Inc. | 5 | $127 |
| Mallinckrodt Hospital Products Inc. | 6 | $116 |
| Invivyd Inc | 3 | $73 |
| Mirum Pharmaceuticals, Inc. | 3 | $73 |
| Ethicon US, LLC | 1 | $43 |
| ORPHALAN INC | 2 | $38 |
Products named: REZDIFFRA, IQIRVO, OCALIVA, XIFAXAN, TERLIVAZ, PEMGARDA, Livmarli, VISTASEAL.
Industry payments across GA — which companies pay providers there.
